Advertisement

Ads Placeholder
Loading...

Bio-Techne Corporation

TECH•NASDAQ
Healthcare
Biotechnology
$53.13
$-0.35(-0.65%)
U.S. Market opens in 32h 27m

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.3B
P/E Ratio102.09
EPS (TTM)$0.53
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$42.78
3 Months$50.12
1 Year Target$52.86

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 102.09 and a market capitalization of 8.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.65%
5-Day Change
0.97%
1-Month Change
-6.77%
3-Month Change
-10.93%
6-Month Change
-15.60%
Year-to-Date (YTD) Change
-10.93%
1-Year Change
-3.15%
3-Year Change
-27.97%
5-Year Change
-46.44%
All-Time (Max) Change
48473.78%

Contact Information

https://www.bio-techne.com
612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

31,000 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions